ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 190 filers reported holding ABCELLERA BIOLOGICS INC in Q3 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3,094,492 | -53.0% | 305,478 | -54.1% | 0.01% | -64.5% |
| Q3 2022 | $6,581,000 | +222.3% | 665,422 | +246.9% | 0.03% | +244.4% |
| Q2 2022 | $2,042,000 | +107.3% | 191,799 | +290.1% | 0.01% | +200.0% |
| Q3 2021 | $985,000 | -2.4% | 49,165 | +7.2% | 0.00% | -25.0% |
| Q2 2021 | $1,009,000 | -34.4% | 45,857 | +1.2% | 0.00% | -42.9% |
| Q1 2021 | $1,539,000 | – | 45,305 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DCVC Bio GP, LLC | 29,411 | $313,000 | 100.00% |
| Founders Fund VII Management, LLC | 3,773,530 | $40,188,000 | 93.02% |
| Gruss & Co., LLC | 363,778 | $3,874,000 | 26.99% |
| Founders Fund Growth Management, LLC | 407,017 | $4,334,000 | 12.66% |
| GUARDIAN CAPITAL ADVISORS LP | 3,836,414 | $44,387,000 | 5.09% |
| HARVARD MANAGEMENT CO INC | 4,105,095 | $43,719,000 | 5.06% |
| Intellectus Partners, LLC | 1,089,755 | $11,606,000 | 3.99% |
| ArchPoint Investors | 630,326 | $6,713,000 | 2.66% |
| BRANDYWINE MANAGERS, LLC | 56,976 | $607,000 | 1.49% |
| Orbimed Advisors | 4,180,768 | $44,525,000 | 0.81% |